Neomycin enhances extracellular matrix stability of glutaraldehyde crosslinked bioprosthetic heart valves

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 99 B, Issue 2, 2011, Pages 217-229

  Friebe, Vincent M ^a   Mikulis, Brandon ^b   Kole, Sourav ^a   Ruffing, Christy S ^a   Sacks, Michael S ^b   Vyavahare, Naren R ^a  

^a South   (United States)

^b PA 15260   (United States)

Author keywords

enzymes; glycosaminoglycan; porcine aortic valve; tissue fatigue; tissue fixation

Indexed keywords

AORTIC HEART VALVES; AORTIC VALVES; BIAXIAL TENSIONS; BIOMECHANICAL ANALYSIS; BIOPROSTHETIC HEART VALVES; COLLAGEN DENATURATION; COLLAGENASE; CROSSLINKED; CROSSLINKS; CYCLIC FATIGUE; ELASTASE; ENZYMATIC DEGRADATION; EXTRACELLULAR MATRICES; GLUTARALDEHYDES; GLYCOSAMINOGLYCANS; HEART VALVE REPLACEMENT; IN-VITRO; MATRIX; PROTEOLYTIC DEGRADATION; TISSUE FIXATION; ULTRASTRUCTURAL ANALYSIS;

ALDEHYDES; ANTIBIOTICS; BIOMECHANICS; BLOOD VESSELS; CATALYSTS; DEGRADATION; ENZYMES; HISTOLOGY; HYSTERESIS; STIFFNESS MATRIX; TRANSMISSION ELECTRON MICROSCOPY;

TISSUE;

COLLAGENASE; ELASTASE; GLUTARALDEHYDE; NEOMYCIN;

ANIMAL TISSUE; ARTICLE; CROSS LINKING; EXTRACELLULAR MATRIX; HEART VALVE BIOPROSTHESIS; HYSTERESIS; MOLECULAR STABILITY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DENATURATION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTI-BACTERIAL AGENTS; AORTIC VALVE; BIOPROSTHESIS; CALORIMETRY, DIFFERENTIAL SCANNING; COLLAGEN; CROSS-LINKING REAGENTS; ELASTIN; EXTRACELLULAR MATRIX; GLUTARAL; GLYCOSAMINOGLYCANS; HEART VALVE PROSTHESIS; MICROSCOPY, ELECTRON, TRANSMISSION; NEOMYCIN; SWINE; TEMPERATURE;

EID: 80054108972     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31889     Document Type: Article

References (57)

1. Simionescu D,. Artificial heart valves. In:, Akay M, editor. Wiley's Encyclopedia of Biomedical Engineering. Hoboken, NJ: John Wiley and Sons; 2006.
2. Sacks MS, David Merryman W, Schmidt DE,. On the biomechanics of heart valve function. J Biomech 2009; 42: 1804-1824.
3. Zilla P, Brink J, Human P, Bezuidenhout D,. Prosthetic heart valves: Catering for the few. Biomaterials 2008; 29: 385-406. (Pubitemid 350100792)
4. Schoen FJ, Levy RJ,. Tissue heart valves: Current challenges and future research perspectives. J Biomed Mater Res 1999; 47: 439-465. (Pubitemid 29468549)
5. Cheung DT, Tong D, Perelman N, Ertl D, Nimni ME,. Mechanism of crosslinking of proteins by glutaraldehyde. IV: In vitro and in vivo stability of a crosslinked collagen matrix. Connect Tissue Res 1990; 25: 27-34.
6. Nimni ME, Cheung DT, Strates B, Kodama M, Sheikh K,. Bioprosthesis derived from cross-linked and chemically modified collagenous tissues. In:, Nimni ME, editor. Collagen, Vol. 3. Boca Raton, Fl: CRC Press; 1988. p 1.
7. Cheung DT, Nimni ME,. Mechanism of crosslinking of proteins by glutaraldehyde II. Reaction with monomeric and polymeric collagen. Connect Tissue Res 1982; 10: 201-216. (Pubitemid 13234870)
8. Lovekamp JJ, Simionescu DT, Mercuri JJ, Zubiate B, Sacks MS, Vyavahare NR,. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials 2006; 27: 1507-1518. (Pubitemid 41739577)
9. Mercuri JJ, Lovekamp JJ, Simionescu DT, Vyavahare NR,. Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization. Biomaterials 2007; 28: 496-503. (Pubitemid 44602237)
10. Simionescu DT, Lovekamp JJ, Vyavahare NR,. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: Implications for bioprosthetic heart valve degeneration. J Heart Valve Dis 2003; 12: 217-225. (Pubitemid 36411104)
11. Vyavahare N, Ogle M, Schoen FJ, Zand R, Gloeckner DC, Sacks M, Levy RJ,. Mechanisms of bioprosthetic heart valve failure: Fatigue causes collagen denaturation and glycosaminoglycan loss. J Biomed Mater Res 1999; 46: 44-50. (Pubitemid 29233179)
12. Flanagan TC, Pandit A,. Living artificial heart valve alternatives: A review. Eur Cell Mater 2003; 6: 28-45. (Pubitemid 38860653)
13. Schoen FJ,. Evolving concepts of cardiac valve dynamics: The continuum of development, functional structure, pathobiology, and tissue engineering. Circulation 2008; 118: 1864-1880.
14. Grande-Allen KJ, Mako WJ, Calabro A, Shi Y, Ratliff NB, Vesely I,. Loss of chondroitin 6-sulfate and hyaluronan from failed porcine bioprosthetic valves. J Biomed Mater Res A 2003; 65: 251-259. (Pubitemid 37521432)
15. Shah SR, Vyavahare NR,. The effect of glycosaminoglycan stabilization on tissue buckling in bioprosthetic heart valves. Biomaterials 2008; 29: 1645-1653.
16. Scott JE, Stockwell RA,. Cartilage elasticity resides in shape module decoran and aggrecan sumps of damping fluid: Implications in osteoarthrosis. J Physiol 2006; 574: 643-650. (Pubitemid 44101366)
17. Perumal S, Antipova O, Orgel JP,. Collagen fibril architecture, domain organization, and triple-helical conformation govern its proteolysis. Proc Natl Acad Sci U S A 2008; 105: 2824-2829. (Pubitemid 351723628)
18. Mavrilas D, Sinouris EA, Vynios DH, Papageorgakopoulou N,. Dynamic mechanical characteristics of intact and structurally modified bovine pericardial tissues. J Biomech 2005; 38: 761-768. (Pubitemid 40248462)
19. Sacks MS, Mirnajafi A, Sun W, Schmidt P,. Bioprosthetic heart valve heterograft biomaterials: Structure, mechanical behavior and computational simulation. Expert Rev Med Devices 2006; 3: 817-834. (Pubitemid 46017622)
20. Simionescu DT, Lovekamp JJ, Vyavahare NR,. Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves. J Biomed Mater Res A 2003; 66: 755-763. (Pubitemid 37521399)
21. Simionescu DT, Lovekamp JJ, Vyavahare NR,. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: An ultrastructural study. J Heart Valve Dis 2003; 12: 226-234. (Pubitemid 36411105)
22. Talman EA, Boughner DR, Glutaraldehyde fixation alters the internal shear properties of porcine aortic heart valve tissue. Ann Thorac Surg 60: S369-S373, 1995.
23. Sacks MS, Yoganathan AP,. Heart valve function: A biomechanical perspective. Philos Trans R Soc Lond B Biol Sci 2007; 362: 1369-1391. (Pubitemid 47195029)
24. Billiar KL, Sacks MS,. Biaxial mechanical properties of the native and glutaraldehyde-treated aortic valve cusp: Part II-A structural constitutive model. J Biomech Eng 2000; 122: 327-335.
25. Mirnajafi A, Raymer JM, McClure LR, Sacks MS,. The flexural rigidity of the aortic valve leaflet in the commissural region. J Biomech 2006; 39: 2966-2973. (Pubitemid 44792110)
26. Raghavan D, Starcher BC, Vyavahare NR,. Neomycin binding preserves extracellular matrix in bioprosthetic heart valves during in vitro cyclic fatigue and storage. Acta Biomater 2009; 5: 983-992.
27. Lovekamp J, Vyavahare N,. Periodate-mediated glycosaminoglycan stabilization in bioprosthetic heart valves. J Biomed Mater Res 2001; 56: 478-486. (Pubitemid 32606008)
28. Salmen S, Hoechstetter J, Kasbauer C, Paper DH, Bernhardt G, Buschauer A,. Sulphated oligosaccharides as inhibitors of hyaluronidases from bovine testis, bee venom and Streptococcus agalactiae. Planta Med 2005; 71: 727-732. (Pubitemid 41306192)
29. Raghavan D, Simionescu DT, Vyavahare NR,. Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves. Biomaterials 2007; 28: 2861-2868. (Pubitemid 46482657)
30. Raghavan D,. ECM stabilization strategies for bioprosthetic heart valves for improved durability. Ph.D. dissertation, Clemson University, South Carolina. 2008.
31. Farndale RW, Buttle DJ, Barrett AJ,. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986; 883: 173-177. (Pubitemid 16027978)
32. de Jong JG, Wevers RA, Liebrand-van Sambeek R,. Measuring urinary glycosaminoglycans in the presence of protein: An improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue. Clin Chem 1992; 38: 803-807.
33. Isenburg JC, Karamchandani NV, Simionescu DT, Vyavahare NR,. Structural requirements for stabilization of vascular elastin by polyphenolic tannins. Biomaterials 2006; 27: 3645-3651.
34. Grashow JS, Yoganathan AP, Sacks MS,. Biaixal stress-stretch behavior of the mitral valve anterior leaflet at physiologic strain rates. Ann Biomed Eng 2006; 34: 315-325.
35. Grashow JS, Sacks MS, Liao J, Yoganathan AP,. Planar biaxial creep and stress relaxation of the mitral valve anterior leaflet. Ann Biomed Eng 2006; 34: 1509-1518.
36. Gloeckner DC, Billiar KL, Sacks MS,. Effects of mechanical fatigue on the bending properties of the porcine bioprosthetic heart valve. ASAIO J 1999; 45: 59-63. (Pubitemid 30428363)
37. Engelmayr GC, Jr., Rabkin E, Sutherland FW, Schoen FJ, Mayer JE Jr., Sacks MS,. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Biomaterials 2005; 26: 175-187. (Pubitemid 38789100)
38. Iyengar AKS, Sugimoto H, Smith DB, Sacks MS,. Dynamic in vitro quantification of bioprosthetic heart valve leaflet motion using structured light projection. Ann Biomed Eng 2001; 29: 963-973. (Pubitemid 34055198)
39. Mirnajafi A, Raymer J, Scott MJ, Sacks MS,. The effects of collagen fiber orientation on the flexural properties of pericardial heterograft biomaterials. Biomaterials 2005; 26: 795-804. (Pubitemid 39179964)
40. Mirnajafi A, Raymer JM, McClure LR, Sacks MS,. The flexural rigidity of the aortic valve leaflet in the commissural region. J Biomech 2006; 39: 2966-2973. (Pubitemid 44792110)
41. Mirnajafi A, Zubiate B, Sacks MS,. Effects of cyclic flexural fatigue on porcine bioprosthetic heart valve heterograft biomaterials. J Biomed Mater Res A 2010; 94: 205-213.
42. Sacks MS,. The biomechanical effects of fatigue on the porcine bioprosthetic heart valve. J Long Term Eff Med Implants 2001; 11: 231-247. (Pubitemid 34211357)
43. Sugimoto H, Sacks MS,. The effects of leaflet stiffness on the dynamic geometry of the bioprosthetic aortic heart valve. Ann Biomed Eng. Forthcoming.
44. Hunziker EB, Schenk RK,. Structural organization of proteoglycans in cartilage. In:, Wight TN, Mecham RP, editors. Biology of ProteoglycansSand Diego. California: Academic Press; 1987. p 155-185.
45. Girish KS, Kemparaju K,. The magic glue hyaluronan and its eraser hyaluronidase: A biological overview. Life Sci 2007; 80: 1921-1943. (Pubitemid 46601516)
46. Jackson RL, Busch SJ, Cardin AD,. Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes. Physiol Rev 1991; 71: 481-539.
47. Fessel G, Snedeker JG,. Evidence against proteoglycan mediated collagen fibril load transmission and dynamic viscoelasticity in tendon. Matrix Biol. Forthcoming.
48. Gupta V, Barzilla JE, Mendez JS, Stephens EH, Lee EL, Collard CD, Laucirica R, Weigel PH, Grande-Allen KJ,. Abundance and location of proteoglycans and hyaluronan within normal and myxomatous mitral valves. Cardiovasc Pathol 2009; 18: 191-197.
49. Orgel JP, Eid A, Antipova O, Bella J, Scott JE,. Decorin core protein (decoron) shape complements collagen fibril surface structure and mediates its binding. PLoS One 4: e7028, 2009.
50. Schoen FJ, Levy RJ,. Calcification of tissue heart valve substitutes: Progress toward understanding and prevention. Ann Thorac Surg 2005; 79: 1072-1080. (Pubitemid 40288798)
51. Julien M, Létouneau DR, Marois Y, Cardou A, King MW, Guidoin R, Chachra D, Lee JM,. Shelf-life of bioprosthetic heart valves: A structural and mechanical study. Biomaterials 1997; 18: 605-612. (Pubitemid 27186869)
52. Bhatia A, Vesely I,. The effect of glycosaminoglycans and hydration on the viscoelastic properties of aortic valve cusps. Conf Proc IEEE Eng Med Biol Soc 2005; 3: 2979-2980. (Pubitemid 46229548)
53. Yang L, Dordick JS, Garde S,. Hydration of enzyme in nonaqueous media is consistent with solvent dependence of its activity. Biophys J 2004; 87: 812-821. (Pubitemid 39095064)
54. Samouillan V, Dandurand-Lods J, Lamure A, Maurel E, Lacabanne C, Gerosa G, Venturini A, Casarotto D, Gherardini L, Spina M,. Thermal analysis characterization of aortic tissues for cardiac valve bioprostheses. J Biomed Mater Res 1999; 46: 531-538.
55. Shanmugam G, Polavarapu PL,. Structural transition during thermal denaturation of collagen in the solution and film states. Chirality 2009; 21: 152-159.
56. Miles CA, Avery NC, Rodin VV, Bailey AJ,. The increase in denaturation temperature following cross-linking of collagen is caused by dehydration of the fibres. J Mol Biol 2005; 346: 551-556.
57. Human P, Zilla P,. Inflammatory and immune processes: The neglected villain of bioprosthetic degeneration?. J Long Term Eff Med Implants 2001; 11: 199-220. (Pubitemid 34211355)